Market Value650,276,000
Total Holdings65
File Date2021-08-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RNA / Avidity Biosciences, Inc.
EDIT / Editas Medicine, Inc.
LNTH / Lantheus Holdings, Inc.
BEAM / Beam Therapeutics Inc.
CUTR / Cutera, Inc.
CAREMAX INC / COM CL A (14171W103)
RVNC / Revance Therapeutics, Inc.
US38341PAA03 / Gossamer Bio Inc
RFL / Rafael Holdings, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
MSON / Misonix Inc
KDMN / Kadmon Holdings Inc
PCVX / Vaxcyte, Inc.
PIRS / Pieris Pharmaceuticals, Inc.
AXGN / Axogen, Inc.
EOLS / Evolus, Inc.
ASMB / Assembly Biosciences, Inc.
MORF / Morphic Holding, Inc.
KNTE / Kinnate Biopharma Inc.
US92538T1043 / VESPER HEALTHCARE ACQUISITION CORP A
OSH / Oak Street Health Inc
US4330001144 / Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A at an
ONCR / Oncorus, Inc.
MRTX / Mirati Therapeutics, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
ARYD / ARYA Sciences Acquisition Corp IV
US10806XAB82 / Bridgebio Pharma, Inc.
RPTX / Repare Therapeutics Inc.
/ RENALYTIX AI PLC-ADR DEPOSITARY RECEIPT
KYMR / Kymera Therapeutics, Inc.
OCX / OncoCyte Corporation
MDXG / MiMedx Group, Inc.
NEO / NeoGenomics, Inc.
PAYX / Paychex, Inc.
BCAB / BioAtla, Inc.
STAA / STAAR Surgical Company
HOWL / Werewolf Therapeutics, Inc.
CDNA / CareDx, Inc
MGTA / Magenta Therapeutics Inc
MRK / Merck & Co., Inc.
CMAX / CareMax, Inc.
TRIL / Trillium Therapeutics Inc
FLXN / Horizon Funds - Horizon Flexible Income ETF
ATXS / Astria Therapeutics, Inc.
DRIO / DarioHealth Corp.
TCRR / Tcr2 Therapeutics Inc
ALPN / Alpine Immune Sciences, Inc.
SIEN / Sientra, Inc.
ADVM / Adverum Biotechnologies, Inc.
CRDF / Cardiff Oncology, Inc.
GH / Guardant Health, Inc.
HALO / Halozyme Therapeutics, Inc.
TKNO / Alpha Teknova, Inc.
TPTX / Turning Point Therapeutics Inc
CRSP / CRISPR Therapeutics AG
DXCM / DexCom, Inc.
LUNG / Pulmonx Corporation
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
CVRX / CVRx, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
SPRY / ARS Pharmaceuticals, Inc.
IRMD / IRADIMED CORPORATION
PHG / Koninklijke Philips N.V. - Depositary Receipt (Common Stock)
GLTO / Galecto, Inc.
SRRK / Scholar Rock Holding Corporation
YMAB / Y-mAbs Therapeutics, Inc.
CELC / Celcuity Inc.
NARI / Inari Medical, Inc.
PODD / Insulet Corporation
SKIN / The Beauty Health Company
EXEL / Exelixis, Inc.
ISEE / IVERIC bio Inc
INSP / Inspire Medical Systems, Inc.
NPCE / NeuroPace, Inc.
EDAP / EDAP TMS S.A. - Depositary Receipt (Common Stock)
KRYS / Krystal Biotech, Inc.
INBX / Inhibrx Biosciences, Inc.
EPIX / ESSA Pharma Inc.
FDMT / 4D Molecular Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
CCCC / C4 Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
XENE / Xenon Pharmaceuticals Inc.
NTRA / Natera, Inc.
ESTA / Establishment Labs Holdings Inc.
LYRA / Lyra Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
SRDX / Surmodics, Inc.
NVCR / NovoCure Limited
RVMD / Revolution Medicines, Inc.
THTX / Theratechnologies Inc.